Page 29 - Read Online

Zhang et al. Hepatoma Res 2020;6:77 I http://dx.doi.org/10.20517/2394-5079.2020.74 Page 5 of 7

DECLARATIONS
Authors’ contributions
Conceived the review: Zhang CZ, Li N

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work is supported from Shanghai Education Committee of Shuguang Plan (18SG32), the National Key
Basic Research Program “973 project” (2015CB555400), the General Program from Shanghai Municipal
Health Commission (201740249).

Conflicts of interest
Both authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional
perspective. Oncologist 2010;15:5-13.
2. Alazawi W, Cunningham M, Dearden J, Foster GR. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C
infection. Aliment Pharmacol Ther 2010;32:344-55.
3. Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in
compensated cirrhosis: a systematic review and meta-analysis. Hepatology 2015;61:526-36.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
5. Kaiser K, Mallick R, Butt Z, Mulcahy MF, Benson AB, Cella D. Important and relevant symptoms including pain concerns in
hepatocellular carcinoma (HCC): a patient interview study. Support Care Cancer 2014;22:919-26.
6. Chaiteerakij R, Roberts LR. Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: insights from next
generation DNA sequencing. J Hepatol 2013;58:1042-4.
7. Zhang XP, Gao YZ, Chen ZH, et al. An eastern hepatobiliary surgery hospital/portal vein tumor thrombus scoring system as an aid to
decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus: a multicenter study. Hepatology
2019;69:2076-90
8. Lee HS. Management of patients with hepatocellular carcinoma and extrahepatic metastasis. Dig Dis 2011;29:333-8.
9. Wong R, Frenette C. Updates in the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) 2011;7:16-24.
10. Toyoda H, Kumada T, Tada T. Highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein: a new tool for the management of
hepatocellular carcinoma. Oncology 2011;81:61-5.
11. Au JS, Frenette CT. Management of hepatocellular carcinoma: current status and future directions. Gut Liver 2015;9:437-48.
12. Bodzin AS, Busuttil RW. Hepatocellular carcinoma: advances in diagnosis, management, and long term outcome. World J Hepatol
2015;7:1157-67.
13. Liu Y, Wang YR, Dingi GH, et al. Influence of surgical resection of hepatocellular carcinoma(HCC) for hematogenous dissemination of
HCC cells and its effect on recurrence and metastasis: 3 years prospective study. Neoplasma 2015;62:635-40.
14. Lacaze L, Scotté M. Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma. World J Hepatol 2015;7:1755-60.
15. Arima K, Chikamoto A, Hashimoto D, et al. Education and imaging. hepatology: hepatocellular carcinoma with duodenal metastasis. J
Gastroenterol Hepatol 2015;30:1115.
16. Fang JH, Zhou HC, Zhang C, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-
mesenchymal transition-independent manner. Hepatology 2015;62:452-65.